Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.68B | $3.07B | $3.37B | $3.59B | $3.13B | $3.33B | $7.32B | $9.62B | $5.38B | $5.14B |
| Revenue growth | — | 14.7% | 9.9% | 6.4% | -12.8% | 6.4% | 120.0% | 31.4% | -44.1% | -4.4% |
| Gross profit | $970M | $1.11B | $1.22B | $1.26B | $995M | $998M | $3.07B | $1.19B | $62.5M | $669M |
| Gross margin | 36.2% | 36.0% | 36.1% | 35.0% | 31.8% | 30.0% | 42.0% | 12.3% | 1.2% | 13.0% |
| Operating income | $601M | $572M | $912M | $666M | $506M | $798M | $2.47B | $252M | -$1.78B | -$367M |
| Operating margin | 22.4% | 18.6% | 27.0% | 18.6% | 16.2% | 24.0% | 33.7% | 2.6% | -33.0% | -7.1% |
| Net income | $644M | $54.9M | $694M | $533M | $376M | $124M | $2.69B | $1.57B | -$1.18B | -$511M |
| Net margin | 24.0% | 1.8% | 20.6% | 14.9% | 12.0% | 3.7% | 36.7% | 16.4% | -21.9% | -9.9% |
| EPS (diluted) | $5.68 | $0.49 | $6.34 | $5.02 | $3.52 | $1.06 | $22.84 | $13.36 | -$11.20 | -$5.76 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $736M | $304M | $546M | $719M | $799M | $344M | $1.91B | $1.33B | $688M | $1.28B |
| Capital expenditures | $197M | $318M | $700M | $852M | $850M | $954M | $1.26B | $2.15B | $1.68B | $590M |
| Free cash flow | $539M | -$13.7M | -$154M | -$132M | -$51.6M | -$609M | $646M | -$828M | -$993M | $692M |
| Share buybacks | $0.00 | $250M | $500M | $0.00 | $0.00 | — | — | — | — | — |
| Dividends paid | $135M | $141M | $145M | $152M | $162M | $178M | $184M | $187M | $189M | $191M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.27B | $1.14B | $555M | $613M | $747M | $439M | $1.50B | $890M | $1.19B | $1.62B |
| Total assets | $8.16B | $7.75B | $7.58B | $9.86B | $10.5B | $11.0B | $15.5B | $18.3B | $16.6B | $16.4B |
| Long-term debt | $2.12B | $1.42B | $1.40B | $2.86B | $2.77B | $2.00B | $3.21B | $3.54B | $3.12B | $3.12B |
| Shareholders' equity | $3.80B | $3.67B | $3.59B | $3.93B | $4.27B | $5.63B | $7.98B | $9.41B | $9.96B | $9.53B |
| Retained earnings | $2.12B | $2.04B | $2.57B | $2.94B | $3.16B | $3.10B | $5.60B | $6.99B | $5.48B | $4.61B |
| Shares (wtd avg diluted) | 113M | 112M | 109M | 106M | 107M | 117M | 118M | 118M | 118M | 118M |
Every figure is extracted from ALBEMARLE CORP’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.